Andrew Barazia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Andrew Barazia has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Amber Olson
Division of Hematology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 2
1 shared publication - Babak Razani
University of Pittsburgh School of Medicine and University of Pittsburgh Medical Center (UPMC), PA (B.R.).
1 shared publication - Bum-Kyu Lee
Department of Biomedical Sciences, Cancer Research Center, College of Integrated Health Sciences, University at Albany, State University of New York, Rensselaer, USA
1 shared publication - Jaehyung Cho
Division of Hematology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA
1 shared publication - Jing Li
University of Illinois – Chicago Chicago IL
1 shared publication - Jonghwan Kim
Department of Molecular Biosciences, The University of Texas at Austin, Austin, USA
1 shared publication
Latest Publications
- Open Access
- 9 November 2021
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 219 (1)
Neutrophil DREAM promotes neutrophil recruitment in vascular inflammation
The interaction between neutrophils and endothelial cells is critical for the pathogenesis of vascular inflammation. However, the regulation of neutrophil adhesive function remains not fully understood. Intravital microscopy demonstrates that neutrophil DREAM promotes neutrophil recruitment to sites of inflammation induced by TNF-α but not MIP-2 or fMLP. We observe that neutrophil DREAM represses expression of A20, a negative regulator of NF-κB activity, and enhances expression of pro-inflammatory molecules and phosphorylation of IκB kinase (IKK) after TNF-α stimulation. Studies using genetic and pharmacologic approaches reveal that DREAM deficiency and IKKβ inhibition significantly diminish the ligand-binding activity of β2 integrins in TNF-α–stimulated neutrophils or neutrophil-like HL-60 cells. Neutrophil DREAM promotes degranulation through IKKβ-mediated SNAP-23 phosphorylation. Using sickle cell disease mice lacking DREAM, we show that hematopoietic DREAM promotes vaso-occlusive events in microvessels following TNF-α challenge. Our study provides evidence that targeting DREAM might be a novel therapeutic strategy to reduce excessive neutrophil recruitment in inflammatory diseases.
- 9 November 2021
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 219 (1)
Open AccessNeutrophil DREAM promotes neutrophil recruitment in vascular inflammation
The interaction between neutrophils and endothelial cells is critical for the pathogenesis of vascular inflammation. However, the regulation of neutrophil adhesive function remains not fully understood. Intravital microscopy demonstrates that neutrophil DREAM promotes neutrophil recruitment to sites of inflammation induced by TNF-α but not MIP-2 or fMLP. We observe that neutrophil DREAM represses expression of A20, a negative regulator of NF-κB activity, and enhances expression of pro-inflammatory molecules and phosphorylation of IκB kinase (IKK) after TNF-α stimulation. Studies using genetic and pharmacologic approaches reveal that DREAM deficiency and IKKβ inhibition significantly diminish the ligand-binding activity of β2 integrins in TNF-α–stimulated neutrophils or neutrophil-like HL-60 cells. Neutrophil DREAM promotes degranulation through IKKβ-mediated SNAP-23 phosphorylation. Using sickle cell disease mice lacking DREAM, we show that hematopoietic DREAM promotes vaso-occlusive events in microvessels following TNF-α challenge. Our study provides evidence that targeting DREAM might be a novel therapeutic strategy to reduce excessive neutrophil recruitment in inflammatory diseases.